MabCure Receives U$500,000.00 Licensing Fee as Well as 12.5% Ongoing Royalty for Its Prostate Cancer Diagnostic Technology - http://us.rd.yahoo.com/finance...
Mabcure Study Results on a New Ovarian Cancer Diagnostic Blood Test Being Presented at the Annual Meeting of the Society of Gynecological Oncologists - http://finance.yahoo.com/news...
MabCure Generates Tumor Specific Antibodies against Prostate Cancer Which Could Lead to a Blood/Urine Diagnostic Test for Prostate Cancer - http://finance.yahoo.com/news...
MabCure Signs a Collaboration Agreement with a Leading Medical Center in Europe for a Study Aimed at Further Development of a Blood Test for Ovarian Cancer - http://finance.yahoo.com/news...